| PRD_001052 | Name: | N-acetyl-L-alpha-aspartyl-L-valyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | Formula: | C18 H28 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001048 | Name: | N-acetyl-L-valyl-L-alpha-aspartyl-L-valyl-N-[(2R)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | Formula: | C23 H37 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001013 | Name: | Peptide Inhibitor (ACE)ADVAD-CHO | Formula: | C21 H33 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_000786 | Name: | Peptide inhibitor (ACE)VDV(3PX)D-CHO | Formula: | C28 H47 N5 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_000431 | Name: | CASPASE-7 INHIBITOR AC-DMQD-CHO | Formula: | C20 H33 N5 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000425 | Name: | Caspase-2 Inhibitor; Ac-VDVAD-Cho | Formula: | C23 H39 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000422 | Name: | Ac-Asp-Glu-Val-Asp-Aldehyde | Formula: | C20 H32 N4 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000391 | Name: | 5-S-benzyl-3-({N-[(5-bromo-2-methoxyphenyl)acetyl]-L-valyl}amino)-2,3-dideoxy-5-thio-D-erythro-pentonic acid | Formula: | C26 H33 Br N2 O6 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000331 | Name: | N-[(benzyloxy)carbonyl]-L-alpha-aspartyl-L-alpha-glutamyl-L-valyl-L-aspartic acid | Formula: | C26 H34 N4 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|